High-quality phase 3 studies do not support the use of somatostatin analogues to reduce vomiting in malignant bowel obstruction.

Publisher:
Springer Nature
Publication Type:
Journal Article
Citation:
Support Care Cancer, 2023, 31, (4), pp. 211
Issue Date:
2023-03-14
Filename Description Size
s00520-023-07669-8.pdf363.77 kB
Adobe PDF
Full metadata record
Please use this identifier to cite or link to this item: